ES8303394A1 - Un procedimiento para preparar un derivado de 2-(2-benzofuranil) e tanolamina. - Google Patents
Un procedimiento para preparar un derivado de 2-(2-benzofuranil) e tanolamina.Info
- Publication number
- ES8303394A1 ES8303394A1 ES505801A ES505801A ES8303394A1 ES 8303394 A1 ES8303394 A1 ES 8303394A1 ES 505801 A ES505801 A ES 505801A ES 505801 A ES505801 A ES 505801A ES 8303394 A1 ES8303394 A1 ES 8303394A1
- Authority
- ES
- Spain
- Prior art keywords
- benzofuran
- medicine
- processes
- preparation
- ethanolamine derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- MMYHYUKBRNCYOG-UHFFFAOYSA-N 2-aminoethanol;1-benzofuran Chemical class NCCO.C1=CC=C2OC=CC2=C1 MMYHYUKBRNCYOG-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000003579 anti-obesity Effects 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000005113 hydroxyalkoxy group Chemical group 0.000 abstract 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
Abstract
METODO DE FABRICACION DE UNA PELICULA ORIENTADA BLAXIALMENTE DE POLIMEROS DE METILESTIRENO. LA PELICULA COMPRENDE UN POLIMERO TERMOPLASTICO DE ALTO PESO MOLECULAR QUE CONSTA ESENCIALMENTE DE POLI(P-METILESTIRENO), CONTENIENDO PREFERENTEMENTE MENOS DEL 5 POR 100 DE UNIDADES DE META-METILESTIRENO Y ESTA SUSTANCIALMENTE EXENTO DE UNIDADES DE ORTOMETILESTIRENO, MENOS DEL 0,1 POR 100, TENIENDO EL POLIMERO UNA TEMPERATURA DE TRANSICION VITREA SUPERIOR A 100 GRADOS C. SE PUEDEN INCORPORAR CARGAS, COLORANTES, ABRILLANTADORES OPTICOS, ESTABILIZANTES, PIGMENTOS Y AGENTES DESLIZANTES. SE PREPARA POR METODOS CONVENCIONALES DE PRODUCCION DE PELICULAS SOLIDAS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8031228 | 1980-09-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8303394A1 true ES8303394A1 (es) | 1983-02-01 |
| ES505801A0 ES505801A0 (es) | 1983-02-01 |
Family
ID=10516329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES505801A Granted ES505801A0 (es) | 1980-09-26 | 1981-09-25 | Un procedimiento para preparar un derivado de 2-(2-benzofuranil) e tanolamina. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4432993A (es) |
| EP (1) | EP0051917B1 (es) |
| JP (1) | JPS5785383A (es) |
| AU (1) | AU546104B2 (es) |
| CA (1) | CA1175851A (es) |
| DE (1) | DE3173816D1 (es) |
| ES (1) | ES505801A0 (es) |
| GR (1) | GR75048B (es) |
| IE (1) | IE52076B1 (es) |
| NZ (1) | NZ198389A (es) |
| PT (1) | PT73712B (es) |
| ZA (1) | ZA816567B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8615995D0 (en) * | 1986-07-01 | 1986-08-06 | Glaxo Group Ltd | Veterinary preparations |
| GB8707122D0 (en) * | 1987-03-25 | 1987-04-29 | Pfizer Ltd | Antiarrhythmic agents |
| US5151439A (en) * | 1990-05-04 | 1992-09-29 | American Cyanamid Company | Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles |
| US5061727A (en) * | 1990-05-04 | 1991-10-29 | American Cyanamid Company | Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles |
| US5106867A (en) * | 1990-05-04 | 1992-04-21 | American Cyanamid Company | Method of increasing lean meat in edible animals |
| US5245053A (en) * | 1990-05-04 | 1993-09-14 | American Cyanamid Company | Substituted 5-(2-(2-aryl-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxoles |
| AT395849B (de) * | 1991-04-04 | 1993-03-25 | Noe Christian R | Pharmakologisch aktive in position 3 substituierte alpha-aminomethyl-2benzofuranmethanole |
| BR9406823A (pt) * | 1993-06-14 | 1996-03-26 | Pfizer | Aminas secundárias e agentes anti-diabéticos e antiobesidade |
| US5563171A (en) * | 1993-11-05 | 1996-10-08 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists |
| US5578638A (en) * | 1993-11-05 | 1996-11-26 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists |
| US5627200A (en) * | 1994-09-26 | 1997-05-06 | Pfizer Inc | β3 -Adrenoceptor agonists and antagonists for the treatment of intestinal motility disorders, depression, prostate disease and dyslipidemia |
| US6075040A (en) * | 1996-09-05 | 2000-06-13 | Eli Lilly And Company | Selective β3 adrenergic agonists |
| ZA967892B (en) * | 1995-09-21 | 1998-03-18 | Lilly Co Eli | Selective β3 adrenergic agonists. |
| EP0801060A1 (en) * | 1996-04-09 | 1997-10-15 | Pfizer Inc. | Heterocyclic Beta-3 Adrenergenic Agonists |
| EP0827746B1 (en) * | 1996-09-05 | 2002-04-03 | Eli Lilly And Company | Carbazole analogues as selective beta3 adrenergic agonists |
| CO5011072A1 (es) | 1997-12-05 | 2001-02-28 | Lilly Co Eli | Etanolaminas pirazinil substituidas como agfonistas de los receptores |
| AU2003225277A1 (en) * | 2002-05-02 | 2003-11-17 | Robert Harris | Lipid removal from the body |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE663926A (es) * | 1964-05-20 | |||
| US3929836A (en) * | 1965-05-11 | 1975-12-30 | Hoffmann La Roche | 2-(2-Lower alkylamino-1-hydroxy-ethyl)-substituted benzofurans |
| GB1472959A (en) * | 1974-09-26 | 1977-05-11 | Roche Products Ltd | Benzofuran derivatives and a process for the manufacture thereof |
| GB1509300A (en) * | 1975-12-05 | 1978-05-04 | Ici Ltd | Ethanolamine derivatives |
| DE2946058A1 (de) * | 1979-11-15 | 1981-05-21 | I.P.U. Ltd., Nassau | Feuerschutzabschlussvorrichtung |
-
1981
- 1981-09-15 CA CA000385953A patent/CA1175851A/en not_active Expired
- 1981-09-17 NZ NZ198389A patent/NZ198389A/en unknown
- 1981-09-21 GR GR66116A patent/GR75048B/el unknown
- 1981-09-21 PT PT73712A patent/PT73712B/pt unknown
- 1981-09-22 ZA ZA816567A patent/ZA816567B/xx unknown
- 1981-09-23 AU AU75603/81A patent/AU546104B2/en not_active Ceased
- 1981-09-23 DE DE8181304398T patent/DE3173816D1/de not_active Expired
- 1981-09-23 EP EP81304398A patent/EP0051917B1/en not_active Expired
- 1981-09-24 US US06/305,117 patent/US4432993A/en not_active Expired - Fee Related
- 1981-09-25 IE IE2231/81A patent/IE52076B1/en unknown
- 1981-09-25 JP JP56151924A patent/JPS5785383A/ja active Pending
- 1981-09-25 ES ES505801A patent/ES505801A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| IE52076B1 (en) | 1987-06-10 |
| PT73712A (en) | 1981-10-01 |
| ZA816567B (en) | 1982-09-29 |
| AU546104B2 (en) | 1985-08-15 |
| CA1175851A (en) | 1984-10-09 |
| NZ198389A (en) | 1984-03-30 |
| EP0051917B1 (en) | 1986-02-19 |
| AU7560381A (en) | 1982-04-01 |
| PT73712B (en) | 1982-12-30 |
| DE3173816D1 (en) | 1986-03-27 |
| JPS5785383A (en) | 1982-05-28 |
| EP0051917A1 (en) | 1982-05-19 |
| IE812231L (en) | 1982-03-26 |
| US4432993A (en) | 1984-02-21 |
| ES505801A0 (es) | 1983-02-01 |
| GR75048B (es) | 1984-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8303394A1 (es) | Un procedimiento para preparar un derivado de 2-(2-benzofuranil) e tanolamina. | |
| ES8103734A1 (es) | Procedimiento para preparar nuevos derivados de piperidina | |
| ES8103735A1 (es) | Procedimiento para la preparacion de derivados de pipreridi-na | |
| LU90053I2 (fr) | Topotecan et ses sels et dérivés pharmaceutiquement acceptables (Hycamtin) | |
| HU9202615D0 (en) | Method for producing new 1-acyl-piperidine derivatives | |
| ES8107185A1 (es) | Procedimiento para preparar piperidinas y pirrolidinas sus- tituidas | |
| EP0339486A3 (en) | Ester of ascorbic acid 2-phosphate | |
| AU515774B2 (en) | Benzopyran derivatives | |
| ES8401961A1 (es) | Procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil-bencimidazolonas sustituidas. | |
| ES8501410A1 (es) | Un procedimiento para la preparacion de nuevos derivados de fosfolipidos. | |
| ES479820A1 (es) | Procedimiento para la preparacion de isoquinoleinas. | |
| ES463240A1 (es) | Procedimiento para la preparacion de acidos pirazol-1-il-fe-nilaceticos. | |
| IE43847L (en) | N-substituted phenylpiperidine derivatives. | |
| DE58907920D1 (de) | Neue Alkanophenone. | |
| IE781144L (en) | Amido penicillanic acids | |
| ATE81850T1 (de) | 3-aminopropyloxyphenylabkoemmlinge, herstellung und arzneitmittel die sie enthalten. | |
| ES2000907A6 (es) | Procedimiento de preparar compuestos 2-oxaisocefen microbiologicamente activos | |
| ES8105715A1 (es) | Procedimiento de preparar derivados isoquinolinicos | |
| ES455940A1 (es) | Procedimiento para la preparacion de 2,9-dioxatriciclo (4,3,1,03,7) decanos. | |
| ATE18211T1 (de) | Chinolinessigsaeuren und diese enthaltende pharmazeutische zubereitungen. | |
| ES477092A1 (es) | Un procedimiento para la preparacion de nuevos derivados de hidantoina. | |
| ATE25516T1 (de) | Neue carbonsaeure-derivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel. | |
| ES8308558A1 (es) | Un procedimiento para la preparacion de derivados del 4,9-dihidro-4,9-dioxo-1h-nafto (2,3-d)-v-triazol. | |
| ES2007784A6 (es) | Procedimiento para la preparacion de derivados de 1-alquil-ergolinil-tiourea> | |
| ES481603A1 (es) | Un procedimiento para la preparacion de un derivado de la hidantoina. |